Insider Shareholders with Direct Ownership of Sensei Biotherapeutics, Inc. (SNSE)
This section provides a comprehensive overview of the insiders with direct ownership of Sensei Biotherapeutics, Inc. (SNSE). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Sensei Biotherapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 2,551 | 0 | 5,188,337 $2.54 Million | 1 |
Feb 16, 2022
Added 0.05%
|
|
|
H&S Investments I Lp
> 10% Shareholder |
4,361,835 | 0 | 4,425,998 $2.17 Million | 1 |
Feb 08, 2021
Added 49.63%
|
| 2,958,096 | 1,587,302 | 3,653,120 $1.79 Million | 63 |
Jul 31, 2023
Reduced 30.29%
|
|
|
John Celebi
PRESIDENT AND CEO |
127,593 | 26,383 | 105,420 $51,655 | 5 |
Feb 15, 2024
Reduced 5.29%
|
|
Erin Colgan
CHIEF FINANCIAL OFFICER |
72,346 | 14,570 | 67,462 $33,056 | 4 |
Feb 15, 2024
Reduced 5.1%
|
|
Horst Edward Van Der
CHIEF SCIENTIFIC OFFICER |
41,265 | 12,368 | 56,070 $27,474 | 3 |
Feb 15, 2024
Reduced 4.83%
|
|
Patrick Stephen Gallagher
Chief Business Officer |
43,513 | 9,383 | 34,130 $16,723 | 2 |
Feb 15, 2023
Reduced 21.56%
|
| 8,932 | 0 | 25,598 $12,543 | 2 |
Jul 10, 2023
Added 14.85%
|
|
| 23,399 | 0 | 23,399 $11,465 | 2 |
Jul 10, 2023
Added 16.03%
|
|
|
Robert Hamilton Pierce
Chief R&D Officer |
21,000 | 0 | 21,000 $10,290 | 1 |
Feb 15, 2022
Added 50.0%
|
| 8,932 | 0 | 8,932 $4,376 | 2 |
Jul 10, 2023
Added 33.33%
|
|
| 8,932 | 0 | 8,932 $4,376 | 2 |
Jul 10, 2023
Added 33.33%
|
|
|
Samuel Broder
Director |
8,932 | 0 | 8,932 $4,376 | 2 |
Jul 10, 2023
Added 33.33%
|
| 8,932 | 0 | 8,932 $4,376 | 2 |
Jul 10, 2023
Added 33.33%
|
|
| 8,932 | 0 | 8,932 $4,376 | 2 |
Jul 10, 2023
Added 33.33%
|